Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells by Zhu, Haohao et al.
Discovery of two skin-derived dermaseptins and design of a TAT-
fusion analogue with broad-spectrum antimicrobial activity and low
cytotoxicity on healthy cells
Zhu, H., Ding, X., Li, W., Lu, T., Ma, C., Xi, X., ... Chen, T. (2018). Discovery of two skin-derived dermaseptins
and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy




Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2018 the authors.
This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:29. Sep. 2018
Submitted 7 March 2018
Accepted 24 August 2018











2018 Zhu et al.
Distributed under
Creative Commons CC-BY 4.0
OPEN ACCESS
Discovery of two skin-derived
dermaseptins and design of a TAT-
fusion analogue with broad-spectrum
antimicrobial activity and low
cytotoxicity on healthy cells
Haohao Zhu1,2,*, Xiyan Ding1,2,*, Wei Li1, Tulin Lu1, Chengbang Ma2,
Xinping Xi2, Lei Wang2, Mei Zhou2, Roberta Burden2 and Tianbao Chen2
1 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
2 School of Pharmacy, The Queen’s University Belfast, Belfast, United Kingdom
*These authors contributed equally to this work.
ABSTRACT
Two novel peptides belonging to the dermaseptin family, namely DRS-CA-1 and
DRS-DU-1, were encoded from cDNA libraries derived from the skin secretions of
Phyllomedusa camba andCallimedusa (Phyllomedusa) duellmani. Both natural peptides
are highly-conserved and exhibited high potency against wild-type Gram-positive,
Gram-negative bacteria, yeast and antibiotic-resistant bacteria (MRSA and Pseu-
domonas aeruginosa) (MICs 4–8 µM) with no obvious hemolytic activity. Collectively
these results suggest that both peptides may have potential as novel antibiotics.
Additionally, DRS-DU-1 exhibited selective cytotoxicity to tumor cells. The truncated
analogue, DP-1 and TAT-fused DP-1 (namely DP-2) were subsequently synthesised.
It showed that DP-1 had low antimicrobial activity, no hemolytic and cytotoxicity to
tumor cells. However, DP-2 possessed strong antimicrobial activity and the similar
selective, no obvious hemolytic activity and cytotoxicity on normal human cells, but
enhanced cytotoxicity to tumor cells of DRS-DU-1. These findings indicate that the
N-terminus of the dermaseptins may contribute to their bioactivity, and that addition
of the TAT peptide can improve biological activity. The results provide a new insight for
designing novel peptide-based antimicrobial or anticancer agents with low hemolytic
activity and cytotoxicity.
Subjects Biochemistry, Bioengineering, Molecular Biology, Synthetic Biology
Keywords Molecular cloning, Skin secretion, Dermaseptin, Antimicrobial peptide, Cell viability.
INTRODUCTION
Due to the lack of efficacy of current antibiotics against increasing numbers of drug-resistant
pathogens, antimicrobial peptides are considered as the compounds with themost potential
to take over traditional antibiotics against drug-resistant bacteria (Li et al., 2012). Peptides
with antimicrobial and antifungal activity have vital roles in the innate immune system,
which constitutes the first line of defense against a wide range of animal-invading pathogens
(Shi et al., 2014; Chen et al., 2006). The skin secretions of frogs from all around the world
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have been proven to be a valuable source of these antimicrobial peptides, with more than
one thousand antimicrobial peptides with significant different structural features having
been extracted and characterized (Erspamer et al., 1985; Azevedo-Calderon et al., 2011).
Dermaseptins are the largest family of antimicrobial peptides identified from the skin
secretions of Phyllomedusa species. Although they show some differences in their lengths,
they are clearly related, given that almost all members are K-rich polycationic peptides,
with a tryptophan residue at position 3 and a highly-conserved motif in the central or
C-terminal region (Nicolas & El Amri, 2009). Peptides belonging to the dermaseptin family
normally have two apparent separated lobes of hydrophobicity and a positively-charged
electrostatic surface, resulting in the coil-to-helix transition upon association with lipid
bilayers (Chen, Tang & Shaw, 2003; Wang et al., 2008). The dermaseptins usually have
lytic activity and are lethal against Gram-positive and Gram-negative bacteria, fungi and
protozoa at micromolar concentrations (Shin et al., 1994). Despite dermaseptins having
identical amino acid sequences, they show significant differences in their efficiency and
cytolytic activities, which was thought to be independent of the envelope structure of
bacteria (Rivas, Luque-Ortega & Andreu, 2009; Navon-Venezia et al., 2002; Huang et al.,
2017). The antimicrobial potency of dermaseptin S3 (from Phyllomedusa sauvagii) was
not affected after shortening its chain length, the truncated N-terminal domain still
retained complete or even better lytic activity against some bacteria (Kustanovich et al.,
2002). Besides, the truncated analogues, such as K4-S4(1-13)a and K4-S4(1-15)a from
dermaseptin S4, exhibited even lower cytotoxic effect on erythrocytes than the parent
peptide (Shepherd, Vogel & Tieleman, 2003; Feder, Dagan & Mor, 2000a).
Although most dermaseptins were discovered by their antimicrobial activity, they
were still reported to be effective against the cancer cells. Dermaseptin B2 and B3
(from Phyllomedusa bicolor) exhibited potent anti-proliferative effect on PC-3 cells, and
dermaseptin B2 inhibited the tumor growth of PC-3 cells in vivo (Van Zoggel et al., 2012b;
Van Zoggel et al., 2012a). The further study showed that dermaseptin B2 could interact
with glycosaminoglycan (GAGs) on the surface of PC-3 for cell internalization (Santos
et al., 2017). Besides, dermaseptin PH (from Pithecopus hypochondrialis), PD1 and PD2
(from Pachymedusa dacnicolor) were reported to exhibit cytotoxicity against several human
cancer cell lines (Huang et al., 2007; Shi et al., 2016).
In this study, we report two novel dermaseptins, namely DRS-CA-1 and DRS-DU-1,
that were discovered by molecular cloning from cDNA libraries derived from the skin
secretion of Phyllomedusa camba and Callimedusa (Phyllomedusa) duellmani. The mature
peptides were subsequently synthesized by solid-phase peptide synthesis and purified for
functional assays. In addition, two analogues were designed based on the results to study
the potential cytotoxicity to tumor cells of dermaseptins.
MATERIALS AND METHODS
Specimen biodata and secretion harvesting
Adult specimens of P. camba and C. duellmani were obtained from commercial sources
(PeruBiotech E.I.R.L., Lima, Peru). Before harvesting the skin secretion, all frogs were
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cultivated in the purpose-designed amphibian facility for at least four months, conditioned
at 20−25 ◦Cwith 12h/12 h light/dark cycle and fed with multivitamin-loaded crickets three
times per week. The defensive skin secretions were produced by stimulation the glands
on the skin surface of frogs with gentle transdermal electrical stimulation (6V DC; 4 ms
pulse-width; 50 Hz) through platinum electrodes for two periods of 20 s duration. The
study was performed according to the guidelines in the UK Animal (Scientific Procedures)
Act 1986, project license PPL 2694, issued by the Department of Health, Social Services
and Public Safety, Northern Ireland. Procedures had been vetted by the IACUC of Queen’s
University Belfast, and approved on 1st March, 2011.
Molecular cloning of the dermaseptin peptide precursor-encoding
cDNAs
Five milligrams of crude lyophilized skin secretions were used to obtain polyadenylated
mRNA using the Dynabeads R© mRNA DIRECTTM kit (Dynal Biotech Ltd, Wirral, UK).
cDNA library construction and primary cDNA amplification were performed with
a BD SMARTTM RACE cDNA amplification kit (BD Biosciences, UK) to give full-
length prepro-peptide nucleic acid sequence data. The degenerate sense primer (S1;
5′-ACTTTCYGAWTTRYAAGMCCAAABATG-3′) (Y = C + T, W = A + T, R = A + G,
M = A + C, B = T + C + G) applied in the RACE reactions were designed according to
the highly conserved domain of the 5′-untranslated region of dermaseptin cDNAs from
Phyllomedusa species. RACE products were subjected to gel analysis, and the detected bands
were purified and cloned using the pGEM R©-T Easy vector system (Promega, Madison, WI,
USA). The sequences were obtained from an ABI 3100 automated capillary sequencer.
Reverse phase HPLC fractionation of crude skin secretion and
amino-acid sequence analysis of relevant peptides
A further fivemilligrams of lyophilised skin secretionwere dissolved in 0.5ml of 0.05% (v/v)
trifluoroacetic acid (TFA)/water and clarified by centrifugation. The clear supernatant was
subjected to reverse-phase HPLC on an analytical column (Jupiter C-5, 250 mm×10 mm;
Phenomenex, Cheshire, UK), eluted with a 0–80% linear gradient of acetonitrile containing
0.05% (v/v) TFA in 240 min at a flow rate of 1 ml/min. Absorbance was monitored at
214 nm. The peptide mapping of two natural occurring peptides was conducted using
MS/MS fragmentation sequencing against the cDNA encoding peptide precursors by LCQ
electrospray ion-trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA).
Solid-Phase Peptide Synthesis
Both the natural peptides and the analogs were chemically synthesized through the solid-
phase method with standard Rink amide resin and Fluorenylmethoxycarbonyl (Fmoc)
chemistry in a PS4 automated solid-phase synthesizer (Protein Technologies, Inc, Tucson,
AZ, USA). After cleavage from the resin and the protecting groups, the crude peptides were
purified and analyzed by reverse-phase HPLC and MALDI-TOF mass spectrometry.
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Secondary structure and physicochemical properties prediction of
the peptides
I-TASSER webserver was applied to predict the secondary structures of the synthetic
peptides (Roy, Kucukural & Zhang, 2010). Physiochemical properties of the peptides were
predicted byHeliquest and the helical wheel plots of the secondary structures were obtained
from the helical wheel projections (Gautier et al., 2008).
In addition, circular dichroism (CD) analyses were performed on the JASCO J815
Spectropolarimeter (JASCO Inc., Easton,MD,USA). Themeasure range of each sample was
190–260 nm, and the parameters were set as follows: 0.5 nmdata pitch, 1 nmbandwidth and
200 nm/min scanning speed. The peptide samples were prepared with 10 mM ammonium
acetate buffer and 50% trifluoroethanol (TFE) in 10 mM ammonium acetate buffer at
a concentration of 100 µM. The percentage of the α-helix structure was predicted by
BESTSEL online software (Micsonai et al., 2015).
Antimicrobial assays
Gram-positive bacteria Staphylococcus aureus (NCTC10788), methicillin-resistant
Staphylococcus aureus (MRSA) (NCTC12493), and Enterococcus faecalis (NCTC 12697);
Gram-negative bacteria Escherichia coli (NCTC 10418), Pseudomonas aeruginosa (ATCC
27853), and Klebsiella pneumoniae (ATCC 43816), and the yeast Candida albicans (NCYC
1467) were chosen to determine the antimicrobial activities of synthesized peptides through
evaluating the minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC). The microorganisms were cultured in Muller Hinton Broth (MHB,
Oxoid, UK)medium and incubated in the orbital incubator (Stuart, UK) at 37 ◦C overnight
and then sub-cultured in a pre-warmed MHB medium until the bacteria reached their
respective logarithmic growth phases. The sub-cultured suspension was diluted with fresh
medium to a concentration of 5×105 colony forming units (CFU)/ml. The peptides with
different concentrations were prepared in DMSO from 512 µM to 1 µM. The MICs were
determined in 96-well microtiter plates by mixing the peptides with bacteria, and 1%
DMSO in MHB was applied as the negative control. After an incubation of 20 h, the
growth of microorganisms was detected at a wavelength of 550 nm in a Synergy HT plate
reader (Biolise BioTek EL808, Winooski, VT, USA). The MICs were determined as the
lowest concentration of peptide where no apparent growth of the microorganism was
detectable. Subsequently, 10 µl of solution in each well was spotted on the Mueller Hinton
Agar (MHA) plates. The MBC values were determined as the lowest concentration of
peptide where no growth was observed on the MHA plate.
Hemolysis assay
Fresh defibrinated horse blood (TCS Biosciences Ltd, Buckingham, UK) was used to
perform the hemolysis assay. The serum and erythrocytes were separated by centrifugation
and the erythrocytes were collected and washed with PBS. Peptides in concentration
gradients were incubated with 4% (v/v) erythrocyte suspension at 37 ◦C for 2 h. 1% DMSO
and triton X-100 (Sigma Aldrich, St. Louis, MO, USA) was used as the negative and positive
control, respectively. After centrifugation, 100 µl supernatants were transferred to a 96-well
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plate and absorbancemeasured at 550 nmusing a SynergyHTplate reader (BioTec, Auburn,
CA, USA). Peptide concentration causing 50% hemolysis of the red bloods cells (HC50)
was calculated [% haemolysis= (A− A0)/ (AX− A0)×100, where ‘A’ is absorbance with
peptides of different concentrations, ‘A0′is absorbance with negative controls and ‘AX’ is
absorbance with positive controls] to determine the hemolysis activities. The therapeutic
index (TI) was calculated as HC50 divided by the geometric mean of the MIC values against
relevant bacteria.
Cell lines and cell culture
Human prostate carcinoma cell line PC-3 (ATCC-CRL-1435), non-small cell lung cancer
cell line H157 (ATCC-CRL-5802), breast cancer cell line MDA-MB-435s (ATCC-HTB-
129), neuronal glioblastoma cell line U251MG (ECACC-09063001) and breast cancer
non-tumorigenic mammary gland cell line MCF-7 (ATCC-HTB-22) were utilized to
screen the cytotoxicity of synthetic peptides. PC-3 and H157 cell lines were cultured in
RPMI-1640 medium (Invitrogen, Paisley, UK), and the other cell lines were cultured with
Dulbecco’s Modified Eagle’s medium (DMEM) (Sigma, St. Louis, MO, USA). Culture
media was supplemented with 10% fetal bovine serum (FBS) (Sigma, Welwyn Garden
City, UK) and 1% penicillin streptomycin solution (Sigma, UK). The human mammary
epithelial cell line, HMEC-1 (ATCC-CRL-3243) was used to evaluate the cytotoxicity of
the synthetic peptides against normal human cells, and cultured with MCDB131 medium
(Gibco, Paisley, UK) with 10% FBS, 10ng/ml EGF, 10mM L-Glutamine and 1% penicillin
streptomycin. The selected cell lines were resuscitated and transferred into a 75 cm2 culture
flask, and then incubated at 37 ◦C atmosphere containing 5% CO2.
Assessment of antiproliferative activity with the MTT assay
MTT cell viability assay was used to assess the proliferation and viability of different cell
lines. After cell quantification, the cell suspension was mixed with pre-warmed medium
to the final concentration of 5 × 103 cells in 96-well plates. After treating with serum-free
medium, various concentrations of peptides were added and incubated for 24 h, 1%
DMSO in related culture media was treated as the negative control. A total of 10 µl of
MTT solution (5 mg/ml) (Sigma, Welwyn Garden City, UK) was added to each well and
incubated for 4 h. Supernatants were removed by syringe and 100 µl of DMSO was used
to resuspend the insoluble purple formazan crystals. The absorbance of each well was
measured at 570 nm with the Synergy HT plate reader (BioTek, Winooski, VT, USA), data
were analysed to obtain the mean and standard error of responses. The dose–response
curves were constructed using a ‘‘best-fit’’ algorithm and then the half maximal inhibitory
concentrations (IC50) were calculated through the data analysis package provided in
GraphPad Prism 6 (GraphPad Software, USA).
RESULTS
Identification of two dermaseptins from their skin secretion and
bioinformatic analyses of novel peptides
Two novel peptides, namely DRS-CA-1 and DRS-DU-1, were encoded from two different
cDNA libraries derived from P. camba and C. duellmani, which were the first dermaseptin
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Figure 1 Translated amino acid sequence of the open-reading frame and nucleotide sequence of
cloned cDNA encoding the biosynthetic precursor of DRS-CA-1 (A) from Callimedusa (Phyllomedusa)
camba and DRS-DU-1 (B) from Phyllomedusa duellmani. The putative signal peptides are marked with
double line, mature peptides are marked with single line and stop codons are indicated by an asterisk.
Full-size DOI: 10.7717/peerj.5635/fig-1
discovered from respective frog species. The nucleotide and translated open-reading frame
consisting of 76 amino acid sequences are shown in Fig. 1. Both contain 16-residue signal
peptide regions, followed by a 16-residue Glu-rich acidic peptide spacer and 28-residue
mature peptide with typical dermaseptin sequence, connected by two -KR- propeptide
convertase processing sites. The extension (-GEQ-) was also observed, of which G acted
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DRS-CA-1 ALWKDLLKNVGKAAGKAVLNKVTDMVNQ.NH2 25.3 0.291 0.263 +3
DRS-DU-1 ALWKSLLKNVGKAAGKAALNAVTDMVNQ.NH2 27.9 0.331 0.255 +3
DP-1 ALWKSLLKNVGKA.NH2 16.1 0.429 0.645 +3
DP-2 GRKKRRQRRRGALWKSLLKNVGKA.NH2 11.4 −0.112 0.358 +11
as a donor for C-terminal amidation of mature peptides. LC-MS analysis confirmed the
presence of DRS-CA-1 and DRS-DU-1 in the skin secretion of P. camba and C. duellmani,
respectively, possessing the post-translational modification of C-terminal amidation
(Figs. 2A and 2B). Alignment of the full length nucleic acid sequences and the open-
reading frame sequences of the two cloned precursors are shown in Fig. 3. Both nucleotide
and amino acid sequences demonstrated high degree of similarity (92%) between two
biosynthetic precursors. Specifically, there was only one residue different in the signal
peptides and three residues different in the mature peptides between the two moieties.
A BLAST search in the Nonredundant Protein Sequence Database showed that several
dermaseptins isolated from different frog species share a high degree of identity of amino
acid sequences with the two dermaseptins identified herein and their open-reading frame
sequences also exhibited remarkable similarities in the acidic peptides (Fig. 3). The cDNA
sequences of two dermaseptin precursors have been deposited in the GenBank Database
under the accession codes MF955846 and MF955847.
Design, synthesis, physicochemical properties and secondary
structure prediction of peptides and their analogues
Considering the length of dermaseptin, N-terminal of 13-mer truncated mimetic peptide,
DP-1, was designed following the previous study (Feder, Dagan & Mor, 2000b). In the
meantime, the TAT (GRKKRRQRRR) peptide was introduced at the N-terminal of
DP-1 to improve its cell-penetration ability, namely DP-2. A Gly was added as a linker
between TAT and DP-1. Both dermaseptins and the designed analogues were successfully
synthesized and purified.
The predicted physicochemical properties and secondary structures of the peptides are
shown in Table 1 and Fig. 4, respectively. Both natural peptides had 3 positive net charges
and possessed α-helical secondary structure. Additionally, the calculated α-helicity of the
natural peptides based on the CD spectra is 23.5% and 27.9%, respectively. However, DP-1
had lower degree of helicity as 16.1% though it had the same net charges and relatively
higher hydrophobicity and hydrophobic moment. Whilst, DP-2 contained the lowest
helical content of 11.4%. Helical wheel plots of four peptides are shown in Fig. 4C. The
two natural peptides formed the hydrophobic face, which are associated with antimicrobial
activity of peptides. However, both DP-1 andDP-2 revealed no uninterrupted hydrophobic
face.
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Figure 2 Identification of (A) DRS-CA-1 and (B) DRS-DU-1 from the corresponding skin secretions. The retention times of DRS-CA-1 and
DRS-DU-1 are indicated by arrows in the respective HPLC chromatograms. The spectra and the tables beside demonstrate the peptide mapping
using the SEQUEST algorithm.
Full-size DOI: 10.7717/peerj.5635/fig-2
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Figure 3 (A) Alignment of nucleotide sequences of cloned cDNAs encoding the biosynthetic precur-
sors of DRS-CA-1 and DRS-DU-1. (B) Alignment of open-reading frame sequences of DRS-CA-1, DRS-
DU-1 and other dermaseptin peptides characterized from other species. (DRS-PS1 from P. sauvagii (ac-
cession number P24302), DRS-H2 from P. hypochondrialis (accession number P84597) and DRS-B4 from
P. bicolor (accession number P81486)). Conserved amino acid residues are shaded in black.
Full-size DOI: 10.7717/peerj.5635/fig-3
Antimicrobial and hemolytic activities
The MIC, MBC and HC50 values of all the peptides obtained from antimicrobial and
hemolysis assays are summarized in Table 2. The two natural peptides, DRS-CA-1 andDRS-
DU-1, showed the same MIC values (4 µM) against S. aureus and E. coli and C. albicans.
DRS-DU-1 was twofold more potent against MRSA, E. faecalis, K. pneumoniae and P.
aeruginosa than DRS-CA-1. The MBC values of two natural peptides against seven tested
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Figure 4 CD spectra of the four peptides (100µM) in 10 mM ammonium acetate buffer (A) and 50%
TFE ammonium acetate buffer (B). Helical wheel projections (Gautier et al., 2008) of peptides (C), with
the arrow indicated the direction of the hydrophobic moments. All the peptides exhibit random coil
structure in the aqueous solution while they are able to form α-helical structure in the membrane-mimetic
environment. The hydrophobic (yellow), hydrophilic (purple), positively-charged (blue), negatively-
charged (red), amide (pink) and small (grey) residues are presented.
Full-size DOI: 10.7717/peerj.5635/fig-4
Table 2 Antimicrobial (MIC andMBC) and hemolytic (HC50) activity, and relative safety (TI) of DRS-
CA-1, DRS-DU-1, DP-1, and DP-2. Data represent the mean of ≥3 determinations.
Strains MIC/MBC (µM)
DRS-CA-1 DRS-DU-1 DP-1 DP-2
S. aureus 4/16 4/16 64/128 8/8
MRSA 8/32 4/16 128/128 16/16
E. faecalis 128/256 64/128 256/>512 32/128
E. coli 4/16 4/16 64/128 4/8
P. aeruginosa 8/32 4/16 128/256 8/16
K. pneumoniae 8/128 4/64 128/>512 32/256
C. albicans 4/16 4/16 32/64 4/8
Horse Erythrocytes (HC50) 114.7 216.6 >512 >512
TI (overall) 21.73 54.15 13.93 147.13
microorganisms were two or four-fold higher than respective MICs. No obvious hemolysis
activity was detected at the MIC or MBC concentrations except against E. faecalis.
The two designed peptides also exhibited broad spectrum antimicrobial activities against
the seven tested microorganisms, though the potency of DP-1 was much lower. However,
the antimicrobial activities of DP-2 were restored comparing to DP-1. Additionally,
the antimicrobial potency of DP-2 on E. faecalis was higher than the natural peptides.
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Table 3 IC50 of DRS-CA-1, DRS-DU-1, DP-1, and DP-2 against tested human cancer cells and human normal cell. The cytotoxicity of
dermaseptin B2 (DRSB2), dermaseptin PH (DRSPH), dermaseptin PD1 (DRSPD1) and dermaseptin PD2 (DRSPD2) obtained from published
data were shown in the table for comparison.
Cell lines IC50 (µM)
DRS-CA-1 DRS-DU-1 DP-1 DP-2 DRSB2 DRSPH DRSPD1 DRSPD2
HMEC-1 >100 53.75 >100 >100 NA 4.85 36.35 27.28
H157 >100 8.43 >100 3.21 NA 2.01 NA 6.43
PC-3 >100 21.6 >100 6.75 2.17 11.8 NA 3.17
MDA-MB-435s >100 >100 >100 >100 >10 9.94 NA NA
U251MG >100 >100 >100 >100 NA 2.36 15.08 13.43
MCF-7 >100 >100 >100 >100 NA 0.69 NA NA
Notes.
NA, not tested.
Anti-Proliferative Effects of the Peptides
The anti-proliferative IC50 values of the natural peptides and designed peptides determined
by MTT assay are summarized in Table 3. DRS-CA-1 and DP-1 were found to possess
no obvious anti-proliferative activity against all five human cancer cell lines and normal
human cells. DRS-DU-1 had selective activity against H157 and PC-3 cells, with IC50 values
of 8.43 µM and 21.6 µM, respectively. Although DP-1 had no activity against all cancer
cell lines, the activity of DP-2 was improved considerably, with the IC50 values of 3.21 µM
and 6.75 µM against H157 and PC-3 cells respectively. In addition, the cytotoxicity against
normal human cell line (HMEC-1) of DRS-DU-1 (IC50 of 53.75) was eliminated. The IC50
values of DP-1 and DP-2 against HMEC-1 are both greater than 100 µM.
DISCUSSION
Many bacteria have developed resistance against conventional antibiotics that has pressed
researchers to discover novel antibacterial agents (Neu, 1992). In recent years, antimicrobial
peptides isolated from amphibian skin secretions have become a hot topic in both academic
and industrial drug discovery research. It is believed that most antimicrobial peptides act on
the cell membrane, and can distinguish target from host cells through differences in fluidity
and the negative charge density of their membranes. Such properties make it unlikely for
the bacterial pathogens to become resistant to antimicrobial peptides (Yeaman & Yount,
2003). However, studies reported that the resistance of bacteria to AMPs has emerged
recently, by producing positively-charged molecules on the membrane, and pumping
AMPs out of cells (Joo, Fu & Otto, 2016; Andersson, Hughes & Kubicek-Sutherland, 2016).
Therefore, discovery and design more effective antimicrobial peptide seems to be urgent
and important.
In this study, we aimed to discover novel bioactive peptides from two rarely studied
species of the Phyllomedusidae family, P. camba and C. duellmani. As a result, two novel
dermaseptin peptides were successfully identified. The nucleotide and translated open-
reading frame sequences of the peptides have almost identical signal peptide sequences,
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the same prepropeptide processing site and amino donor. Furthermore, they differ by only
two amino acids in the acidic peptide sequence and three residues in the mature peptides.
Through the NCBI-BLAST search, it is interesting to note that the two novel precursors
not only exhibit high homology to the different types of antimicrobial peptides from the
Phyllomedusidae frogs, but also to other antimicrobial peptides from the Hylidae tree
frogs. More than 80% identity were shared in the signal peptide domain between the two
dermaseptins precursors and the antimicrobial peptides derived from the Hylidae frogs,
including dermatoxin, medusin, caerin, cruzioseptin and phylloseptin (Chen et al., 2005;
Gao et al., 2017; Gao et al., 2016; Pukala et al., 2006; Proano-Bolanos et al., 2016). This is
the reason of the evolution from the ancestors that were selected by the surroundings to
form diverse bioactive peptides for their unique defense system (Vanhoye et al., 2003).
DRS-CA-1 andDRS-DU-1 exhibited strong antimicrobial activity against Gram-positive
and Gram-negative bacteria and fungi with no obvious hemolytic activity, and almost the
same proportion of polar residues and nonpolar residues as well as the α-helical structure.
The positive net charge of antimicrobial peptides had been widely accepted as the key
factor to help the peptide combine with the negatively-charge bacteria cell surface. Besides,
the hydrophobic surface of the peptides in the α-helical structure could ensure the
peptides permeabilize the membrane. Although resistance against antimicrobial peptides
have emerged, this bacterial-killing mechanism of dermaseptin is distinctly different
from conventional antibiotics, which makes it promising in relation to overcoming
antibiotic resistance problems (Lee, Hall & Aguilar, 2016). Comparing to the two most
famous dermaseptins, dermaseptin B2 and S4, both natural peptides demonstrated potent
antimicrobial activities, though dermaseptin B2 showed strongly inhibitory effect on E. coli
(Kustanovich et al., 2002; Joanne et al., 2009). As the studies indicated, more cationicity
of dermaseptin could improve the antimicrobial activity as well as the spectrum, which
is consistent with study of introduce of Lys at positions 7 and 14 of dermaseptin S4
that remarkably increased the antimicrobial activity against P. aeruginosa (Jiang et al.,
2014). Additionally, the study of truncated analogues demonstrated that the integrity
of N-terminus is essential for possessing the antimicrobial activity while reducing the
haemolysis within certain degree (Kustanovich et al., 2002). Therefore, we assumed that
the 13-mer N-terminal truncated analogue, DP-1, will retain the antimicrobial potency of
the patent peptides, but will become less hemolytic. Although the DP-1 had the same ratio
of polar/nonpolar residues, higher hydrophobic moment and same positive net charge,
it might not form the proper α-helical structure resulting in significant reduction of its
antimicrobial activity against all microorganisms. The data is different comparing to the
previous study of the structure–activity relationship of dermaseptin S4 (Kustanovich et
al., 2002), in which peptides with same physico-chemical properties usually have similar
potency. This phenomenon indicates the importance of peptide’s secondary structure in
designing short antimicrobial peptides. Interestingly, when the TAT peptide was added,
its antimicrobial activity was enhanced remarkably with reduced hemolytic activity.
Considering their structural difference, this can be explained by the increased positive
charges, which can enhance the interaction with the negative charge bacterial membranes.
However, research has revealed that a high positive charge could lead to an increased
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hemolytic activity and a loss of antimicrobial potency (Dathe et al., 2001), which is not
corresponding with the results.We hypothesize that TAT peptide associated the attachment
to the surface of bacteria, which subsequently allow the helical region of DP-1 segment to
permeabilize the cell membrane.
Although dermaseptin has been reported to induce necrosis in PC-3 cancer cells, there
are researches showing that dermaseptin could enter the cytoplasm and the nucleus (Santos
et al., 2017; Auvynet et al., 2006). We also noticed that the sensitivity to dermaseptin varies
due to different type of cancer cells. On the sensitive cells, PC-3, researches indicated that
the internalization mechanism may be initiated through the interaction with negatively-
charged glycosaminoglycan (GAGs) (Santos et al., 2017). Therefore, the disappearance of
cytotoxic activity of DP-1 could be the shorter sequence and lower helicity that decreases
the permeability against cell membrane, as well as the affinity to cancer cells for the GAGs
mediated internalization. However, the restore of cytotoxicity activity of DP-2 suggests
that fused-TAT improved the affinity of DP-2 to the cell membrane and initiated the
interaction with GAGs.
On the other hand, the cytotoxicity of antimicrobial peptides on normal mammalian
cells is mostly associated with the hydrophobicity and helicity of those peptides. The
typical membrane lytic peptide, melittin, possesses an average helicity of 70% at membrane
interfaces (Andersson et al., 2013).When reviewing the researches of different dermaseptins,
we found that the increase of helicity not only improved antimicrobial and cytotoxic effect,
but also increased the cytotoxicity on both normal cell lines and erythrocytes [12, 20].
For instance, that dermaseptin-PH showed a α-helicity of 35% may be related to the high
degree of cytotoxicity on HMEC-1 (Huang et al., 2017). The presence of cytotoxicity on
both cancer cells and HMEC-1 of DRS-DU1 than DRS-CA1 could be also speculated
by the higher α-helicity. Additionally, researches of truncated dermaseptin analogues
also indicates that the integrity of α-helix and hydrophobic domain is important for the
bio-activity of dermaseptin (Auvynet et al., 2006). Moreover, that the effects of DP-2 on
HMEC-1 and erythrocytes were remained mild is consistent with the hypothesis of GAGs
involved internalization as proportion of GAGs is larger than which is on the healthy cells.
In summary, two novel dermaseptins were deduced from the skin secretion of P. camba
and C. duellmani with broad-spectrum antimicrobial activity even against drug-resistant
strains (MRSA and Pseudomonas aeruginosa) with low hemolytic activity, which makes
them promising in the treatment of multidrug-resistant bacteria. This study revealed the
importance of the TAT peptide in the design of antimicrobial or anti-proliferative cancer
agents through enhancing their biological function. All of these provide a new idea for
designing novel peptide-based antimicrobial or anti-proliferative agents.
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